Prevalence of DSM-IV psychiatric disorder in the French elderly population

被引:228
作者
Ritchie, K
Artero, S
Beluche, I
Ancelin, ML
Mann, A
Dupuy, AM
Malafosse, A
Boulenger, JP
机构
[1] Hop Colombiere, INSERM E0361, F-34093 Montpellier 5, France
[2] Inst Psychiat, INSERM E0361, London, England
[3] Inst Psychiat, Sect Old Age Psychiat, London, England
[4] Hop Lapeyronie, Dept Biochem, Montpellier, France
[5] Hop Lapeyronie, INSERM E0361, Montpellier, France
[6] Univ Geneva, Dept Psychiat, Geneva, Switzerland
关键词
D O I
10.1192/bjp.184.2.147
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background France has high rates of psychotropic drug consumption and suicide in the elderly population, but it has not yet been possible to determine whether this is due to exceptionally high morbidity rates. Aims To describe the first longitudinal population study of psychiatric disorder undertaken in France, and to estimate current and lifetime prevalences and age of onset of psychiatric disorder. Method A study group of 1873 non-institutionalised persons aged 65 years and over was randomly recruited from the Montpellier district electoral rolls. The Mini International Neuropsychiatric Interview was used to assess current and lifetime symptoms. Cases identified by the application of DSM-IV criteria were reexamined by a clinical panel. Results Forty-six per cent of the study population had experienced a mental disorder in their lifetime, and 3.7% had made a suicide attempt. Lifetime prevalence of major depression was 26.5% and 30% for anxiety disorders. Current prevalence rates were 14.2% for anxiety disorders, 10.7% for phobia, 3% for major depression and 1.7% for psychosis. Conclusions Results show very high rates of lifetime but not current major depression. Rates of current phobia and suicidal ideation in the very elderly are also high compared with other studies. The rates reported are likely to be underestimates. Declaration of interest None. Funding detailed in Acknowledgements.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 29 条
[1]   Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance [J].
Allard, J ;
Artero, S ;
Ritchie, K .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) :874-878
[2]  
Angst J, 1995, ENCEPHALE, V21, P37
[3]   PREVALENCE OF PSYCHIATRIC-DISORDERS IN THE ELDERLY IN EDMONTON [J].
BLAND, RC ;
NEWMAN, SC ;
ORN, H .
ACTA PSYCHIATRICA SCANDINAVICA, 1988, 77 :57-63
[4]   Suicidal ideation among older primary care patients [J].
Callahan, CM ;
Hendrie, HC ;
Nienaber, NA ;
Tierney, WM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (10) :1205-1209
[5]   RANGE OF MENTAL-ILLNESS AMONG THE ELDERLY IN THE COMMUNITY - PREVALENCE IN LIVERPOOL USING THE GMS-AGECAT PACKAGE [J].
COPELAND, JRM ;
DEWEY, ME ;
WOOD, N ;
SEARLE, R ;
DAVIDSON, IA ;
MCWILLIAM, C .
BRITISH JOURNAL OF PSYCHIATRY, 1987, 150 :815-823
[6]   PREVALENCE AND CORRELATES OF DEPRESSION IN A POPULATION OF NONAGENARIANS [J].
FORSELL, Y ;
JORM, AF ;
VONSTRAUSS, E ;
WINBLAD, B .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 :61-64
[7]   The prevalence of diagnoses, impairments, disabilities and handicaps in a population of elderly people living in a defined geographical area: the Gospel Oak project [J].
Harwood, RH ;
Prince, MJ ;
Mann, AH ;
Ebrahim, S .
AGE AND AGEING, 1998, 27 (06) :707-714
[8]  
Katz S, 1963, JAMA-J AM MED ASSOC, P94, DOI DOI 10.1001/JAMA.1963.03060120024016
[9]  
KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
[10]  
Krasucki C, 1998, INT J GERIATR PSYCH, V13, P79, DOI 10.1002/(SICI)1099-1166(199802)13:2<79::AID-GPS739>3.0.CO